Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC
Apply
177Lu Girentuximab, Cabozantinib, Nivolumab
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step